As one of non-receptor tyrosine kinase families, the Janus kinase (Jak) family is composed of four members, Jak1, Jak2, Jak3 and Tyrosine kinase 2 (Tyk2). Each protein has a similar protein structural domain structure: a kinase domain and a catalytically inactive pseudo-kinase domain, and each of them binds to a cytokine receptor via an amino-terminal structural domain. Jaks is able to be activated and phosphorylate the receptor upon binding of a cytokine to its receptor, creating docking sites for signaling molecules. Deficiency of JAK3 often leads to human autosomal recessive severe combined immunodeficiency (SCID), therefore, the development of a selective Jak3 inhibitor has promising therapeutic applications in the treatment of cancer and inflammatory diseases.
BOC Sciences can establish a Janus Kinase (JAK) targeted library that contains 600 molecules.
Figure 1. Principal signaling pathways activated by homodimeric cytokine receptors. (Vainchenker, W.; et al. 2018)
Figure 2. The kinase domain of Janus kinase 2 (JAK2). (Vainchenker, W.; et al. 2018)
BOC Sciences provides professional, rapid and high-quality services of Janus Kinase (JAK) Targeted Library design at competitive prices for global customers. Personalized and customized services of Janus Kinase (JAK) Targeted Library design can satisfy any innovative scientific study demands. Our clients have direct access to our staff and prompt feedback to their inquiries. If you are interested in our services, please contact us immediately!
Reference
BOC Sciences has rich experience in working with global customers in custom library synthesis of compounds and generating small to medium-sized libraries of target compounds. Our knowledge in generating a large number of target molecules in a remarkably shorter time enables quick biological screenings for affinities. With the target properties in mind, we deliver target molecules, by applying our extensive knowledge in drug discovery.